Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control

Coronavirus disease 2019 (COVID-19) is associated with a high risk of mortality and complications in patients with diabetes mellitus. Achieving good glycemic control is very important in diabetic patients to reduce complications and mortality due to COVID-19. Recent studies have shown the mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanan, Niya, Naik, Dukhabandhu, Sahoo, Jayaprakash, Kamalanathan, Sadishkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724202/
https://www.ncbi.nlm.nih.gov/pubmed/36483108
http://dx.doi.org/10.5501/wjv.v11.i6.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724202/
https://www.ncbi.nlm.nih.gov/pubmed/36483108
http://dx.doi.org/10.5501/wjv.v11.i6.399

Ejemplares similares